stockrowLongevity Health Holdings, Inc.
XAGE Consumer Defensive Household & Personal Products
Longevity Health Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, up 3,702.8% from fiscal 2024.
- Revenue
- −21.4%
- EPS
- +51.3%
- Free cash flow
- +73.2%
Quarter to June 2026, against a year earlier
Follow XAGE
Alert me
Longevity Health Holdings, Inc. (XAGE) EV/Sales
As of 4 November 2026, Longevity Health Holdings, Inc. (XAGE) trades at a EV/Sales of 1.0×. Over the past ten years it has ranged from 0.0× (December 2024) to 12.1× (April 2025); the current reading is higher than 79% of that period. That is below the Household & Personal Products industry median of 1.2× and in line with the Consumer Defensive sector median of 1.0×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.6× | (66.98%) |
| FY2024 | 1.9× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.2× | 29.08% |
| Mar 2026 | 1.0× | 51.64% |
| Dec 2025 | 0.6× | (42.34%) |
| Sep 2025 | 1.1× | (61.14%) |
| 6 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| TANH Tantech Holdings Ltd. compare | −0.2× |
| DSY Big Tree Cloud Holdings Limited compare | n/m |
| ATTT Atlas Trinity Tech Limited compare | n/m |
| BYAH Park Ha Biological Technology Co., Ltd. compare | n/m |
| GROV Grove Collaborative Holdings, Inc. compare | 0.3× |
| XAGE Longevity Health Holdings, Inc. | 1.0× |
| BRSHF Bruush Oral Care Inc. compare | 1.2× |
| SLSN Solesence, Inc. compare | 1.5× |
| UG United-Guardian, Inc. compare | 1.9× |
| Household & Personal Products industry median | 1.2× |
| Consumer Defensive sector median | 1.0× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)